Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 28, 2017; 23(48): 8512-8525
Published online Dec 28, 2017. doi: 10.3748/wjg.v23.i48.8512
Published online Dec 28, 2017. doi: 10.3748/wjg.v23.i48.8512
Figure 8 Astragaloside IV suppressed M-CSF and elevated TIMP2 protein expression (A) and secretion (B) in the gastric cancer-associated fibroblasts.
Data are plotted as mean ± SD of three separate experiments. aP < 0.05 and bP < 0.01.
- Citation: Wang ZF, Ma DG, Zhu Z, Mu YP, Yang YY, Feng L, Yang H, Liang JQ, Liu YY, Liu L, Lu HW. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts. World J Gastroenterol 2017; 23(48): 8512-8525
- URL: https://www.wjgnet.com/1007-9327/full/v23/i48/8512.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i48.8512